Stanley Goldfarb, MD, was appointed to the Board of Visitors on July 1, 2024, by Governor Glenn Youngkin.
Dr. Goldfarb is board chairman of Do No Harm. He has had a long career in academic medicine as a Professor of Medicine at the Perelman School of Medicine of the University of Pennsylvania. During that career, Dr. Goldfarb was funded by the National Institutes of Health to conduct research in the mechanism of kidney disease. Dr. Goldfarb has published over 100 articles in peer-reviewed medical journals, such as the New England Journal of Medicine and the Journal of Clinical Investigation. He has also published over 150 invited reviews and commentaries. He has also served on a number of editorial boards of important medical journals, such as the Journal of Clinical Investigation, the Clinical Journal of the American Society of Nephrology, the Journal of Diabetes, and as Editor in Chief of Nephrology Self-Assessment Program (NephSAP), a journal published by the American Society of Nephrology. Dr. Goldfarb has also been active in the world of medical education as the Associate Dean for Curriculum at the Perelman School of Medicine at Penn.
Dr. Goldfarb help found Do No Harm after publication of his book, Take Two aspirins and Call Me by my Pronouns, a call to action to eliminate discriminatory practices in health care, including elevating diversity above meritocracy in the admission of students to medical school and the hiring of faculty members. As Chairman of Do No Harm, Dr. Goldfarb has published widely in various periodicals, including the Wall Street Journal, City Journal, The New York Post, and The Free Press on the threats to medical education and medical care in the United States posed by introduction of critical race theory into these enterprises. In addition, Do No Harm has been in the forefront of organizations combating the experimental treatment of children and adolescents with gender affirming care in the absence of scientific evidence showing its efficacy. Do No Harm is committed to the welfare and safety of these children by demanding that healthcare institutions follow the science and severely restrict this potentially harmful form of treatment.